Eight novel trihybrids as potential anti-Alzheimer's drugs showed high AChEI and anti-Aβ aggregation capacity, moderate anti-ROS activity and low MAO inhibition.
No takes yet. Share an insight, caveat, or question.
Hiremathad et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: